Phase II Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy And Safety Study Of Tanezumab As Add-On Therapy To Opioid Medication In Patients With Pain Due To Bone Metastases.
Phase of Trial: Phase II
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Tanezumab (Primary) ; Opioid analgesics
- Indications Cancer pain
- Focus Therapeutic Use
- 29 Dec 2012 Planned number of patients changed from 58 to 60 as reported by European Clinical Trials Database (Parent trial: EudraCT2008-005181-31).
- 04 Jul 2012 Lead trial investigator identified as reported by Clinical Trials Registry - India (Parent trial: CTRI2011-05-001754).
- 13 Apr 2012 Actual end date Feb 2012 added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History